Psoriatic arthritis: latest treatments and their place in therapy

DOI Web Site Web Site 1 Citations
  • Eun Jin Kang
    Division of Rheumatology, Department of Medicine, Busan Medical Center, Busan, Republic of Korea
  • Arthur Kavanaugh
    Division of Rheumatology, Allergy, and Immunology, Center for Innovative Therapy, University of California, San Diego, 9500 Gilman Drive, Mail Code 0943, La Jolla, CA 92037, USA

Description

<jats:p> Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory disease that may affect peripheral and axial joints, entheses, skin and nails, and other organs. Treatment with nonsteroidal anti-inflammatory drugs, steroid and disease-modifying antirheumatic drugs had been the backbone of traditional management of PsA for many years. However, improvement in our understanding of immunopathogenesis of PsA has led to new immunomodulatory therapies. Introduction of novel agents has raised the bar for treatment and helped drive research into additional therapeutic options. </jats:p>

Journal

Citations (1)*help

See more

Report a problem

Back to top